Cargando…
Cannabinoids in arterial, pulmonary and portal hypertension – mechanisms of action and potential therapeutic significance
The endocannabinoid system is overactivated in arterial, pulmonary and portal hypertension. In this paper, we present limited clinical data concerning the role of cannabinoids in human hypertension including polymorphism of endocannabinoid system components. We underline differences between the acut...
Autores principales: | Malinowska, Barbara, Toczek, Marek, Pędzińska‐Betiuk, Anna, Schlicker, Eberhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487561/ https://www.ncbi.nlm.nih.gov/pubmed/29455452 http://dx.doi.org/10.1111/bph.14168 |
Ejemplares similares
-
Effects of the peripheral CB(1) receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022) -
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
por: Remiszewski, Patryk, et al.
Publicado: (2020) -
Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
por: Weresa, Jolanta, et al.
Publicado: (2022) -
Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
por: Mińczuk, Krzysztof, et al.
Publicado: (2022) -
Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT(3) Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
por: Kossakowski, Rafał, et al.
Publicado: (2019)